Clinical Trial Update: Latanoprost for the Treatment of Menière's Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating latanoprost for Menière's disease; the update indicates the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menière Disease

Drugs mentioned

• Latanoprost (Latanoprost)

Snippet

Sponsor: Synphora AB | Conditions: Menière's Disease | Phase 2 | Status: UNKNOWN